Verantos Receives FDA Support to Demonstrate Advanced Approaches to RWE
Verantos announced that it has received a grant award from the U.S. Food and Drug Administration to implement a multi-year advanced real-world evidence (RWE) study.
The program, "Transforming Real-World Evidence with Unstructured and Structured Data to Advance Tailored Therapy" (TRUST), was sponsored by the FDA Center for Drug Evaluation and Research.
As RWE is increasingly used to make clinical assertions and refine the standard of care, rigorous approaches are required to meet evidentiary standards. This three-year study will apply advanced RWE to a clinical scenario, and data quality will be studied by comparing traditional approaches to advanced approaches. The study, FD-20-030, includes innovations in deep phenotyping, data linkage, and phenotype accuracy measurement.
For more information, click here.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
